Skip to main content
Premium Trial:

Request an Annual Quote

Roche to Develop CDx for DalCor Cardiovascular Drug

NEW YORK (GenomeWeb) – Roche today announced a deal with DalCor Pharmaceuticals to develop a PCR-based companion diagnostic test for a therapeutic being developed by the drug manufacturer for acute coronary syndrome. 

Roche's test will be used in a Phase III clinical trial that seeks to validate the clinical efficacy of the drug called dalcetrapib, a CETP inhibitor. Roche said that a recent study by the Montreal Heart Institute indicated that dalcetrapib could potentially reduce morbidity and deaths resulting from cardiovascular events by as much as 39 percent in patients with a specific genetic profile. 

Roche's test will be developed to identify a specific genetic variation from patients with recent ACS and aid in determining whether a patient is a candidate for DalCor's drug candidate. Annually, more than 1 million hospital admissions in the US are attributed to ACS, Roche noted. 

The test is Roche's first in cardiovascular disease, Paul Brown, head of Roche Molecular Diagnostics, said in a statement. "Working with DalCor is a good opportunity for us to enter this market and deliver on our mission of personalized healthcare," he said. 

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.